Pharmaceuticals
Bristol Myers Squibb to acquire RayzeBio for $4.1 billion in cash
31 Dec 2023
American multinational pharmaceutical company Bristol Myers Squibb on Tuesday said it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business
AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn
27 Dec 2023
Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has agreed to acquire China-based Gracell Biotechnologies Inc, for about $1.2 billion.
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bn
26 Dec 2023
Bristol Myers Squibb on Friday agreed to acquire Karuna Therapeutics, a pioneer in schizophrenia drugs, for $330 per share in cash
.jpg)
Pfizer is set to acquire Seagen for $43 billion and create a new oncology division
13 Dec 2023
In a significant move, Pfizer has announced its anticipation of concluding the $43 billion deal to acquire cancer drug maker Seagen by 16 December 2023.
Western drugmakers pivot to India as tensions with China prompt supply chain shifts
27 Nov 2023
In a strategic move to reduce dependence on Chinese contractors in drug production, global pharmaceutical companies are turning to Indian manufacturers.
